Artemis Investment Management LLP

Position in AMRX — Amneal Pharmaceuticals, Inc.

CIK 1535385 EDINBURGH, X0

Back to AMRX Full portfolio

Position in AMRX

as of Mar 31, 2026 · filed Apr 13, 2026 Compact

Position Value

$2,313,533

+$739,806 QoQ

Shares Held

186,125

+49.0% QoQ

Ownership

0.058%

of shares outstanding

% of Portfolio

0.02%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2025

2 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in AMRX Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Mar 31, 2026

Artemis Investment Management LLP holds $72,198,117 across 4 Drug Manufacturers - Specialty & Generic names. AMRX ranks #2 (3.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ELAN	Elanco Animal Health Inc	2,841,535	$67,997,932
2	AMRX	Amneal Pharmaceuticals, Inc. This page	186,125	$2,313,533
3	ANIP	Ani Pharmaceuticals Inc	15,451	$1,188,181
4	COLL	Collegium Pharmaceutical, Inc	21,121	$698,471

All Filings in AMRX

Export CSV

2 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$2,313,533	186,125	+49.0%	Shares	Sole	2026-04-13
2025-12-31	$1,573,727	124,899	—	Shares	Sole	2026-02-02
No filing history on record for this holder in this stock.